UBS Asset Management Americas Inc. raised its stake in Clorox Co (NYSE:CLX) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 543,231 shares of the company’s stock after buying an additional 8,773 shares during the quarter. UBS Asset Management Americas Inc. owned 0.42% of Clorox worth $80,800,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently added to or reduced their stakes in the company. Dupont Capital Management Corp acquired a new position in Clorox in the third quarter valued at about $199,000. Smith Moore & CO. acquired a new position in Clorox in the third quarter valued at about $204,000. Private Asset Management Inc. acquired a new position in Clorox in the fourth quarter valued at about $208,000. Lourd Capital LLC acquired a new position in Clorox in the fourth quarter valued at about $210,000. Finally, Gratus Capital LLC acquired a new position in Clorox in the third quarter valued at about $215,000. 74.11% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Clorox Co (NYSE:CLX) opened at $126.29 on Thursday. Clorox Co has a fifty-two week low of $124.09 and a fifty-two week high of $150.40. The stock has a market capitalization of $16,664.65, a PE ratio of 20.84, a price-to-earnings-growth ratio of 2.41 and a beta of 0.31. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.35.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is an increase from Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 dividend on an annualized basis and a dividend yield of 3.04%. Clorox’s dividend payout ratio (DPR) is presently 55.45%.
Several equities analysts have weighed in on CLX shares. Jefferies Group reissued a “hold” rating and issued a $132.00 target price on shares of Clorox in a research note on Wednesday, November 1st. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a report on Monday, November 6th. Morgan Stanley lowered their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Wells Fargo & Co increased their price target on Clorox from $130.00 to $146.00 and gave the stock a “market perform” rating in a report on Thursday, January 4th. Finally, Deutsche Bank began coverage on Clorox in a report on Wednesday, December 13th. They issued a “hold” rating and a $142.00 price target for the company. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. Clorox presently has a consensus rating of “Hold” and a consensus target price of $132.46.
In related news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.00% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION WARNING: “UBS Asset Management Americas Inc. Has $80.80 Million Holdings in Clorox Co (CLX)” was first posted by Week Herald and is owned by of Week Herald. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://weekherald.com/2018/02/22/ubs-asset-management-americas-inc-has-80-80-million-holdings-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.